Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Okra and Diabetes: What Research Says About Its Blood Sugar Control Effects

Emerging evidence from clinical and mechanistic studies reveals how okra’s natural compounds lower blood sugar, balance lipids, and support overall metabolic health in diabetes.

Epigenetic Mechanisms in Type 2 Diabetes

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

Diabetic Coma Treatments

Diabetic Neuropathy Pathogenesis

What is Diabetic Retinopathy?

What Causes Diabetes?

History of Diabetes

What is Diabetic Ketoacidosis?

Diabetic Mastopathy Diagnosis

Diabetes and Periodontitis

Supplements for Diabetes

See more featured articles »

Risks to Infants of Diabetic Mothers

How Does Semaglutide Work to Lose Weight?

Diabetes Diagnosis

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

Diabetic Neuropathy Diagnosis

Diabetes Types

Diabetic Retinopathy Risk Factors

Diabetic Mastopathy: Complication of Diabetes Mellitus

Nonketotic Hyperosmolar Coma

Diabetes Complications

Advanced Diabetic Ketoacidosis

How does Gestational Diabetes Affect the Baby?

Diabetes and Sleep

Encapsulating Islet Cells for the Treatment of Diabetes

Research into a Cure for Diabetes

Low Sugar Foods for Diabetes

Diabetes and Skin Problems

How Baking Soda Affects People with Type 2 Diabetes

Vitamin D and Type 2 Diabetes

What is Diabetic Neuropathy?

Diabetic Foot Problems

Diabetes Risk Factors

Treatment and Prognosis for Diabetic Mastopathy

Diabetes and Pregnancy

COVID-19 and Diabetes

Diabetes in Men

Does the Keto Diet Increase the Risk of Diabetes?

Diabetes in Men versus Women

What is HbA1C Testing?

What is Diabetes?

Causes of Foot Pain

The Future of Diabetes Treatment

Diabetes Pathophysiology

Diabetic Retinopathy Treatments

Diabetic Coma Severe Hypoglycemia

Diabetic Neuropathy Treatments

The Impact of Glucagon on Diabetes Management

Animals That Can Detect Hypoglycemia

Artificial Pancreas Systems: The Future of Diabetes Management?

The Risks of Prediabetes

Diabetic Emergencies: What to Do

Cause of Diabetic Coma

Pins and Needles and Diabetes

Diabetic Ketoacidosis Causes

Diabetic Nephropathy Symptoms

Can I reverse my prediabetes naturally

What is Diabetic Nephropathy?

Adiponectin and Diabetes

Diabetes and Wound Healing

Walking After Meals: Small Habit, Big Metabolic Gains

Diabetes Management

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Hypoglycemic Unawareness

What are Nightmares and Why Do They Occur?

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Diabetic Nephropathy Treatment

Diabetes and Mucormycosis

What Causes Diabetic Nephropathy (Kidney Disease)?

Is a Plant-Based Diet Good for Type 2 Diabetes?

What is Diabetic Hypoglycemia?

Alcohol and Diabetes

Effects of Hyperglycemia on the Vascular System

Understanding MODY 5: A Rare Genetic Form of Diabetes

Diabetes and Vision

Red Blood Cell Morphology Changes in Diabetes

Genetic Testing for Diabetes

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Diabetic Hypoglycemia Treatments

Diabetic Neuropathy Symptoms

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Diabetic Retinopathy Diagnosis

Diabetic Retinopathy Symptoms

What is HbA1c?

Diabetes Screening

What is a Diabetic Coma?

Diabetes Symptoms

Diabetic Hypoglycemia Etiology

Latest Diabetes News and Research

Should drug companies be advertising to consumers?

Tamar Abrams had a lousy couple of years in 2022 and '23. Both her parents died; a relationship ended; she retired from communications consulting.

20 Feb 2026

Low oxygen turns red blood cells into powerful glucose sinks

Scientists have long known that people living at high altitudes, where oxygen levels are low, have lower rates of diabetes than people living closer to sea level.

19 Feb 2026

Hypoxia rewires red blood cells to clear excess glucose

In a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low oxygen levels-such as those found at high altitudes.

19 Feb 2026

Genome sequencing data reveals new insights into Epstein-Barr virus immunity

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown.

19 Feb 2026

Syzygium jambolanum extract shows promise for diabetes management

The search for effective and accessible therapies for diabetes continues to draw attention to medicinal plants with a long history of traditional use.

19 Feb 2026

Cyborg transplants may advance cell-based therapies for diabetes

A new electronic implant system can help lab‑grown pancreatic cells mature and function properly, potentially providing a basis for novel, cell-based therapies for diabetes.

19 Feb 2026

Gut microbiome may shape response to GLP-1 drugs, new review suggests

This review examines how GLP-1 receptor agonists and the gut microbiome influence one another through bile acid signaling, short-chain fatty acids, and inflammatory pathways. It explores how microbial composition may shape treatment response and highlights the need for controlled human studies to enable microbiome-informed precision therapy.

19 Feb 2026

Gut bacteria patterns help predict insulin resistance in type 2 diabetes, study finds

Researchers used 16S rRNA sequencing and machine learning to identify gut microbiome patterns associated with insulin resistance severity in people with type 2 diabetes. XGBoost models showed that specific bacterial genera, including Bacteroides and Faecalibacterium, help distinguish individuals with higher insulin resistance from healthy controls.

19 Feb 2026

Monthly produce prescriptions do not improve blood sugar

Findings from a study on produce prescriptions show no significant improvement in blood sugar control, emphasizing the importance of addressing food insecurity.

19 Feb 2026

Intermittent calorie restriction proves as effective as daily calorie cuts for type 2 diabetes

A post-hoc analysis of two clinical trials compared continuous calorie restriction with early time-restricted eating in adults with type 2 diabetes and overweight or obesity over three months. Both approaches improved weight, body composition, and metabolic health, with no clear superiority except for lower dropout with intermittent restriction.

18 Feb 2026

COVID vaccination during pregnancy linked to lower preeclampsia risk

A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication.

18 Feb 2026

Hormone replacement therapy shows no rise in overall mortality

Menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is not associated with an increased risk of death, finds a Danish study of over 800,000 women published by The BMJ today.

18 Feb 2026

How GLP-1 drugs affect the body beyond weight loss and glucose control

This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects, rare but debated risks, and areas where further long-term safety data are still needed.

18 Feb 2026

Macrophage immune memory depends on lingering interferon gamma

Researchers from the University of California, Los Angeles, have discovered that immune cells known as macrophages remain poised to fight repeat infections due to the persistent presence of signaling molecules left behind during previous infections.

18 Feb 2026

Injectable clay-based bandages rapidly stop severe internal bleeding

Traumatic injury is the third leading cause of death in the state of Texas, surpassing strokes, Alzheimer's disease and diabetes, according to the Centers for Disease Control and Prevention.

18 Feb 2026

Lifestyle medicine practice linked to lower clinician burnout

Healthcare professionals report that treating patients with lifestyle medicine helps to reduce burnout by increasing professional satisfaction, meaning, and a sense of effectiveness at work, according to a new study published in BMC Health Services Research.

18 Feb 2026

Undiagnosed diabetes and kidney disease raise heart risk

Diabetes and kidney disease are major risk factors for heart disease, yet many cases are undiagnosed. In addition, a consumer survey done last fall suggests that most people don't realize that their heart, kidney and metabolic health (how the body creates, uses and stores energy) are connected.

18 Feb 2026

Frailty impacts heart attack survival differently by sex

Pioneering research from the University of Leicester and NIHR challenges the 'one-size-fits-all' approach to heart attack care, adding critical nuance to the debate on sex disparities.

18 Feb 2026

Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, inflammatory, mitochondrial, and proteostasis pathways. Evidence from mechanistic, preclinical, and early clinical studies suggests potential neuroprotective effects, but definitive disease-modifying benefit remains unproven.

17 Feb 2026